Insulin Receptor in Pancreatic Cancer—Crown Witness in Cross Examination

SIMPLE SUMMARY: Pancreatic cancer (PDAC) is a highly malignant disease with low survival rates. Due to its close proximity to the insulin producing pancreatic islets, PDAC should be exposed to comparatively higher concentrations of the growth promoting hormone insulin. We wanted to know if PDAC migh...

Descripción completa

Detalles Bibliográficos
Autores principales: Heckl, Steffen M., Kercher, Lukas, Abdullazade, Samir, Schneider, Carolin, Krüger, Sandra, Behrens, Hans-Michael, Sebens, Susanne, Schäfer, Heiner, Schreiber, Stefan, Röcken, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508431/
https://www.ncbi.nlm.nih.gov/pubmed/34638472
http://dx.doi.org/10.3390/cancers13194988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508431/
https://www.ncbi.nlm.nih.gov/pubmed/34638472
http://dx.doi.org/10.3390/cancers13194988

Ejemplares similares